Medicus Pharma Names Carolyn Bonner as New CFO, CEO Thanks Former CFO Jim Quinlan for His Contributions.
ByAinvest
Tuesday, Dec 2, 2025 2:57 am ET1min read
MDCX--
Medicus Pharma has appointed Carolyn Bonner as its new CFO, in addition to her current role as president. Bonner has nearly two decades of experience in healthcare and life sciences and will be responsible for financial reporting, capital markets strategy, and clinical development initiatives. She will also continue to lead corporate planning and cross-functional clinical development initiatives. The appointment aims to enhance continuity, stability, and alignment in Medicus' corporate objectives.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet